Status and phase
Conditions
Treatments
About
The primary outcome of the study is the effect of Hairfinity vs. Placebo on the rate of distal hair growth, assessed using Trichoscan HD, in healthy female adults from baseline to day 90 (end of study).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Female 18-50 years of age (inclusive)
Subject is not of child bearing potential. Defined as females who have had a hysterectomy or oophorectomy, bilateral tubal ligation or are post-menopausal (natural or surgically with > 1 year since last menstruation).
OR
Female subject of childbearing potential must agree to use a medically approved method of birth control and have a negative urine pregnancy test result. Acceptable methods of birth control include:
Fitzpatrick skin type of I-V (See appendix 3)
Willing to maintain the colour of and style of the hair cut for the duration of the study
Willing to maintain shampooing frequency and general hair regime for the duration of the study
Willing to not cut hair for the duration of the study
Willing to have area of hair prepped for Trichoscan analysis
Healthy as determined by laboratory results, medical history, and physical exam
Subjects must agree to comply with study procedures
Has given voluntary, written, informed consent to participate in the study
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
152 participants in 4 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal